As of February 28, 2023, the company has 16,387,552 issued shares (including 1,372 treasury shares held by SHL, which are dormant shares and have no rights) with a nominal value of NIS 0.01 each (Corresponding to 16,386,180 voting rights)
As of February 28, 2023, SHL was aware of the following shareholders with more than 3% of all voting rights in the company:
Including Treasury Shares
Excluding Treasury Shares %
Cai Mengke and Shen Kun
More Provident Funds
Value Base Group
Sphera Funds Management Ltd.
|Danbar Finance Ltd.|
The above table of Significant Shareholders reflects both actual holdings as of Fabruary 28, 2023, excluding options and any other purchase positions, after deducting from the total number of shares outstanding 1,372 Ordinary Shares held by SHL, and actual holdings as of Fabruary 28, 2023 calculated including ordinary shares held by SHL, all as indicated above, but does not reflect holdings on a fully diluted basis. All in accordance with notifications received by the Company from its shareholders as of Fabruary 28, 2023.
Disclosure of Management Transactions
SHL Telemedicine has to report to SIX Swiss Exchange all transactions of SHL shares and options made by the Board of Directors and the executive management. The disclosure of management transactions is intended as a means of furthering the supply of information to investors. Such disclosure provides investors with additional qualitative insight with regard to their investment decision.
Click here for the Management Transaction disclosure of SHL Telemedicine on the SIX-Platform.